论文部分内容阅读
1986年我们利用增敏剂(Uematoporphyrin Derivative简称HPD),开展了对晚期和放射不敏感恶性肿瘤的放射增敏治疗,取得了较好的效果。仅就护理特点报告如下。
In 1986, we used sensitizers (Uematoporphyrin Derivative referred to as HPD) to perform radiosensitization therapy for advanced and radiation-insensitive malignancies, and achieved good results. Only the nursing characteristics are reported below.